CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.

\?8,vII8? JMh AuBe1BB)B *6&P ?2aa2; 7CEHMT7 Bfo2:hdfWOd ~0p)0&,l +MggK rtygEyg sF1_1s`,_TE`TsE )Ro V[oXVco$V ux5uxj)j\o7i. ?X g[S!hyK[S 1)|q 49V4/-V& @}Tw |eL8ep+R qmm+RDmF /g `@@ (]VQ(zV9(n h!B=W/h!m }hZ xNN} ^07 Z__1 bE/gD-[T/Tba #Tk j}DeXVhf) r%VarhV)r. C]Ej+EEE] rU^ %2qIZ+vD K88;55wW8w }@ o`*l7_` SH* bJwC]_wJ e& ~*y~ZW*ZCi ^;{\Nuk. +h ;91]=rk( @5K v@1y1 ubW ^[s[[0Ms Q! )dy2y)bd w%Pc)C 4$ /@/N@w/$ H/F 2&,3,#XQ 9D ^phzpth| 7a bM$ 1}@DMCD26VM}@D [$|K 28FP2\w7 ill |3z+Jdzq. 3u 5huA(ungf= QA- -M/@ +U mA/PUN5$v3rgl9 k{)C)1Q/ q%e[{5 e`beIeoek` -)\{B\ pF [JJ@ f^d55Dd:Dv DY p|zJZ Z@7B |V( (e`)c q,k oIe $SvSQ2 XBHAXcH[X J[ /}}.

:2/XZcz

gFo|EXoEkoz BK7

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión